Previous Events

16.05.2018 Neuropharmacology

FORENSIC FOR WEB

Have you ever wondered how the chemicals we consume affect our brain? Why cocaine makes people feel like they are flying, or antidepressants are able to alleviate feelings of depression and anxiety?

The study of Neuropharmacology focuses on the way drugs affects the nervous system and the neural mechanism. On a molecular level this involves the study of neurons and their neurochemical interactions with the aim to develop the most neurological beneficial drugs and archive a higher understanding of neurodegenerative diseases and psychological disorders.

At this event associate professor Claus Løland will give us a short introduction to how the brain and nerve cells function, and give us an insight into the field of neuropharmacology and his research. At the Løland lab they work with structure-function relationships in membrane transporters, with a particularly emphasis on the Sodium Symporter class of proteins. As part of this they focus on identifying domains undergoing conformational changes during substrate binding and translocation. In addition, they map the binding sites and binding modes for inhibitory drug such as cocaine and antidepressant, as well substrates e.g. dopamine and amphetamine.

This research combines methods from advanced biophysics, biochemistry and molecular pharmacology.

 

02.05.2018 Synthetic Biology

Alger

Synthetic Biology is a new interdisciplinary field within biology in which basic engineering principles are applied to biological systems. It brings together several aspects from other domains such as biotechnology, genetic engineering, molecular biology and biochemistry with the overall purpose of building artificial biological systems for research, engineering and medical applications. The key concept in synthetic biology is standardization of biological parts, achieved by basic technologies such as standardized DNA parts (So-called Biobricks), DNA synthesis, modular protein assemblies as well as modeling.
Although synthetic biology is an upcoming field it is still quite undefined and not very well-known among researcher and student in Denmark.
Speakers: Tomas Laursen is Postdoc in Plant Biochemistry at the department of Plant and Environmental Sciences and currently researching a complex system of “powertool”-proteins located in the membranes of the cells, with the purpose to investigate the relationship between conformational changes of cytochrome P450 reductase and its electron transfer action, providing an understanding on how to regulate the enzyme.

 21.03.2018 Carlsberg Research Laboratory

 carlsberg-group_rgb-copy

Since 1875 the Carlsberg Research Laboratory have received international acknowledgement for their eminent and groundbreaking research which have had a great influence on many scientific fields, particular in bioscience. Some of the most prominent research includes creating a method for quantification of nitrogen in organic compounds, introducing the concept of pH, and revolutionary proteinchemistry research (in particular about proteolytic enzymes and the dynamic nature of proteins).

Today the Carlsberg research laboratory is split into 4 groups of interdisciplinary teams combining expertise in brewing science, chemistry, biochemistry, physiology, genetics, bioinformatics, and  in molecular biology. These teams form the Carlsberg groups, all working  together to further perfect the art of brewing. This event will highlight both previous and current research, as well as the possibilities for jobs and projects within this industry.

Keynote speaker:

Jochen Förster have worked as Director and Professor for Yeast and Fermentation at Carlsberg Groups since 2016. Here he works with the creation of new brewing organisms with improved traits for application in their core-, speciality- and non-alcoholic beers.

07.03.2018 The Gut Microbiota

gut microbiome

The human microbiota is composed of a wide array of microorganisms with roots within all domains of life. Today these microbes are acknowledged for having a tremendous impact on our physiology – as well as our psychological behavior – as they provide us with everything from new metabolic functions and pathogen protection, to education for our immune systems.

In 2016 the ratio of human to microbial cells in the average human body was estimated to be around 1:1. With only a limited amount of the microbes living inside us having been cultured and studied, there is still much research to be undertaken on the microbes taking residence within our bodies. Karsten Kristiansen, professor and head of Laboratory of Genome Research and Molecular Bio Medicine at University of Copenhagen as well as professor and Director of Institute of Metagenomics at BGI-Shenzhen, will be giving us an insight into his research in Copenhagen and Shenzhen. In addition he will provide information about projects and career paths in this rising new field.

 

21.02.2018 Biosynthia – An insight into an upcoming biotech company

Biosyntia-x2
What if you could easily make natural compounds such as vitamins using organic synthesis? Not only could you reduce the cost of production, but you could also obtain a higher quality of your solutions as well as reduce the environmental impact compared to chemical synthesis.

One company had that vision, Biosynthia. Having raised more than 6 millions USD and received several recognitions, including being one of the most innovative SNMEs in Europe, Biosynthia is today one of the most up and coming biotechnological companies.

Co-founder and CSO Hans Genee will, together with a Ph.D student at Biosynthia, give us an insight into who Biosynthia is and their current research. In addition they will also talk about how it is to write a Ph.D – or a project – at Biosynthia and what it takes.

is today one of the most upcoming biotechnology companies.

07.02.2018 Bioentreprenuership

160726_dummy_image16_9_6743_1
What does it take to become a successful entrepreneur, and how do you go from idea to business?
Denmark is today one of the best countries to in which to become an entrepreneur making it an attractive career for students. However knowing how to do start up on your own, and maintain the necessary drive and motivation can be a rather difficult task.
Anne Sophie Vinther Hansen started her journey as a serial entrepreneur at the age of 11 and continued all the way through her studies culminating in the bio company Cumulus Bio which last year was granted 30 million Danish Krones from Innovationsfonden. Today she is working as the Head of investments at Syddansk Innovation. In this kick-off event she will be giving an inspirational talk on her experiences.

Read more about event on Facebook here.